EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

Olfactory Ecto-Mesenchymal Stem Cells in Modeling and Treating Alzheimer’s Disease

Hongmin Wang iD, Abena Dwamena

International Journal of Molecular Sciences · 03.08.2024 · 25 (15) · 8492

DOI: 10.3390/ijms25158492 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift International Journal of Molecular Sciences, online erschienen am 03.08.2024. Verfasst von Hongmin Wang und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacology and Neuroscience, Garrison Institute on Aging, Center of Excellence for Translational Neuroscience and Therapeutics, Texas…. Hauptthemen laut MEDLINE: Alzheimer Disease, Mesenchymal Stem Cells, Mesenchymal Stem Cell Transplantation, Olfactory Mucosa. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 65 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, NIH/NIA.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Alzheimer’s disease (AD) is a condition in the brain that is marked by a gradual and ongoing reduction in memory, thought, and the ability to perform simple tasks. AD has a poor prognosis but no cure yet. Therefore, the need for novel models to study its pathogenesis and therapeutic strategies is evident, as the brain poorly recovers after injury and neurodegenerative diseases and can neither replace dead neurons nor reinnervate target structures. Recently, mesenchymal stem cells (MSCs), particularly those from the human olfactory mucous membrane referred to as the olfactory ecto-MSCs (OE-MSCs), have emerged as a potential avenue to explore in modeling AD and developing therapeutics for the disease due to their lifelong regeneration potency and facile accessibility. This review provides a comprehensive summary of the current literature on isolating OE-MSCs and delves into whether they could be reliable models for studying AD pathogenesis. It also explores whether healthy individual-derived OE-MSCs could be therapeutic agents for the disease. Despite being a promising tool in modeling and developing therapies for AD, some significant issues remain, which are also discussed in the review.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Alzheimer DiseaseMesenchymal Stem CellsMesenchymal Stem Cell TransplantationOlfactory MucosaHumansAnimals

Stichwörter der Autor:innen

Alzheimer’s diseasedifferentiationexosomegliamesenchymal stem cellmodelneuronolfactorytherapeutictransplantation

Autor:innen und Institutionen

  • Department of Pharmacology and Neuroscience, Garrison Institute on Aging, Center of Excellence for Translational Neuroscience and Therapeutics, Texas Tech University Health Science Center, Lubbock, TX 79424, USA.

ORCID-Profile: Hongmin Wang

Förderung

  • NIA NIH HHS
  • NIH/NIA

Zitieren

APA

Wang, H., & Dwamena, A. (2024). Olfactory Ecto-Mesenchymal Stem Cells in Modeling and Treating Alzheimer’s Disease. International Journal of Molecular Sciences, 25(15), 8492. https://doi.org/10.3390/ijms25158492

Vancouver

Wang H, Dwamena A. Olfactory Ecto-Mesenchymal Stem Cells in Modeling and Treating Alzheimer’s Disease. International Journal of Molecular Sciences. 2024;25(15):8492. doi:10.3390/ijms25158492

BibTeX
@article{Wang2024,
  author = {Wang, Hongmin and Dwamena, Abena},
  title = {Olfactory Ecto-Mesenchymal Stem Cells in Modeling and Treating Alzheimer’s Disease},
  journal = {International Journal of Molecular Sciences},
  year = {2024},
  volume = {25},
  number = {15},
  pages = {8492},
  doi = {10.3390/ijms25158492}
}
Kostenlos starten →